48
Views
25
CrossRef citations to date
0
Altmetric
Review

Cholesterol-lowering phytosterols: factors affecting their use and efficacy

, &
Pages 59-72 | Published online: 28 Jul 2010

References

  • Jimenez-Escrig A, Santos-Hidalgo AB, Saura-Calixto F. Common sources and estimated intake of plant sterols in the Spanish diet. JAgric Food Chem. 2006;54:3462–3471.
  • Phillips KM, Ruggio DM, Ashraf-Khorassani M. Phytosterol composition of nuts and seeds commonly consumed in the United States. J Agric Food Chem. 2005;53:9436–9445.
  • Weihrauch JL, Gardner JM. Sterol content of foods of plant origin. J Am Diet Assoc. 1978;73:39–7.
  • Normén L, Bryngelsson S, Johnsson M, et al. The phytosterol content of some cereal foods commonly consumed in Sweden and in the Netherlands. J Food Compost Anal. 2002;15:693–704.
  • Normén L, Johnsson M, Andersson H, van Gameren Y, Dutta P. Plant sterols in vegetables and fruits commonly consumed in Sweden. Eur J Nutr. 1999;38:84–89.
  • Normén AL, Brants HAM, Voorrips LE, Andersson HA, van den Brandt PA, Goldbohm RA. Plant sterol intakes and colorectal cancer risk in the Netherlands Cohort Study on Diet and Cancer. Am J Clin Nutr. 2001;74:141–148.
  • Valsta LM, Lemström A, Ovaskainen ML, et al. Estimation of plant sterol and cholesterol intake in Finland: quality of new values and their effect on intake. Br J Nutr. 2004;92:671–678.
  • Carr TP, Jesch ED. Food ingredients that reduce cholesterol absorption. Adv Food Nutr Res. 2006;51:165–204.
  • Ostlund RE Jr, Racette SB, Okeke A, Stenson WF. Phytosterols that are naturally present in commercial corn oil significantly reduce cholesterol absorption in humans. Am J Clin Nutr 2002;75:1000–1004.
  • Ostlund RE Jr, Racette SB, Stenson WF. Inhibition of cholesterol absorption by phytosterol-replete wheat germ compared with phytosterol-depleted wheat germ. Am J Clin Nutr. 2003;77:1385–1389.
  • Carr TP, Cornelison RM, Illston BJ, Stuefer-Powell CL, Gallaher DD. Plant sterols alter bile acid metabolism and reduce cholesterol absorption in hamsters fed a beef-based diet. Nutrition Research. 2002;22: 745–754.
  • Carr TP, Gallaher DD, Yang C-H, Hassel CA. Increased intestinal contents viscosity reduces cholesterol absorption efficiency in hamsters fed hydroxypropyl methylcellulose. J Nutr 1996;126:1463–1469.
  • Gylling H, Miettinen TA. The effect of cholesterol absorption inhibition on low density lipoprotein cholesterol level. Atherosclerosis. 1995;117:305–308.
  • Kesaniemi YA, Miettinen TA. Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur J Clin Invest. 1987;17:391–395.
  • Rudel LL, Deckelman C, Wilson MD, Scobey M, Anderson R. Dietary cholesterol and downregulation of cholesterol 7a-hydroxylase and cholesterol absorption in African green monkeys. J Clin Invest. 1994; 93:2463–2472.
  • Andersson SW, Skinner J, Ellegard L, et al. Intake of dietary plant sterols is inversely related to serum cholesterol concentration in men and women in the EPIC Norfolk population: a cross-sectional study. Eur J Clin Nutr. 2004;58:1378–1385.
  • Klingberg S, Ellegard L, Johansson I, et al. Inverse relation between dietary intake of naturally occurring plant sterols and serum cholesterol in northern Sweden. Am J Clin Nutr. 2008;87:993–1001.
  • Berger A, Jones PJH, Abumweis SS. Plant sterols: factors affecting their efficacy and safety as functional food ingredients. Lipids Health Dis. 2004;3:5.
  • Ferrari RA, Esteves W, Mukherjee KD, Schulte E. Alteration of sterols and steryl esters in vegetable oils during industrial refining. J Agric Food Chem. 1997;45:4753–757.
  • Nyström L, Paasonen A, Lampi AM, Piironen V Total plant sterols, steryl ferulates and steryl glycosides in milling fractions of wheat and rye. J Cereal Sci. 2007;45:106–115.
  • Vikström F, Holmbom B, Hamunen A. Sterols and triterpenyl alcohols in common pulpwoods and black liquor soaps. European Journal of Wood and Wood Products. 2005;63:303–308.
  • Verleyen T, Sosinska U, Ioannidou S, et al. Influence of the vegetable oil refining procees on free and esterified sterols. J Am Oil Chem Soc. 2002;79:947–953.
  • Phillips KM, Ruggio DM, Toivo JI, Swank MA, Simpkins AH. Free and esterified sterol composition of edible oils and fats. J Food Compost Anal. 2002;15:123–142.
  • World Health Organization. Cardiovascular diseases 2009. Available from: http://www.whoint/mediacentre/factsheets/fs317/en/. Accessed on March 1, 2010.
  • National Center for Health Statistics. Deaths: preliminary data for 2007. 2009 Available from: http://wwwcdcgov/nchs/data/nvsr/nvsr58/nvsr58_01pdf. Accessed on March 1, 2010.
  • British Heart Foundation. European cardiovascular disease statistics 2008. Available from: http://wwwheartstatsorg/temp/ESspweb08spchapter1pdf. Accessed on March 1, 2010.
  • Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: heart sisease and stroke statistics – 2010 update: a report from the American Heart Association. Circulation. 2010;121:948–954.
  • Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239.
  • National Institutes of Health. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Circulation. 2002;106:3143–3421.
  • Bays H. Statin safety: An overview and assessment of the data – 2005. Am J Cardiol. 2006;97 Suppl:6C-26C.
  • Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. NEngl J Med. 2004;350:1495–1504.
  • Kastelein JJP, Akdim F, Stroes ESG, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008; 358:1431–1443.
  • McKenney JM, Davidson MH, Jacobson TA, Guyton JR. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol. 2006;97:89C–94C.
  • Pandor A, Ara RM, Tumur I, et al. Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials. J Intern Med. 2009;265:568–580.
  • Florentin M, Liberopoulos EN, Mikhailidis DP, Elisaf MS. Fibrate- associated adverse effects beyond muscle and liver toxicity. Curr Pharm Des. 2008;14:574–587.
  • Maccubbin D, Koren MJ, Davidson M, et al. Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease. Am J Cardiol. 2009;104:74–81.
  • Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82–96.
  • World Health Organization. Preparation and use of food-based dietary guidelines. Report of a Joint FAO/WHO Consultation. Geneva. WHO Technical Report Series No 880; 1998.
  • Schoenheimer R. New contributions in sterol metabolism. Science. 1931;74:579–584.
  • Hofmann AF, Borgström B. The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J Clin Invest. 1964;43:247–257.
  • Haikal Z, Play B, Landrier JF, et al. NPC1L1 and SR-BI are involved in intestinal cholesterol absorption from small-size lipid donors. Lipids. 2008;43:401–408.
  • Jesch ED, Carr TP. Sitosterol reduces micellar cholesterol solubility in model bile. Nutr Res. 2006;26:579–584.
  • Armstrong MJ, Carey MC. Thermodynamic and molecular determinants of sterol solubilities in bile salt micelles. J Lipid Res. 1987;28:1144–1155.
  • Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res. 1989;30:719–730.
  • Martinez I, Wallace G, Zhang C, et al. Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Appl Environ Microbiol. 2009; 75:4175–4184.
  • Christiansen L, Karjalainen M, Seppanen-Laakso T, Hiltunen R, Yliruusi J. Effect of beta-sitosterol on precipitation of cholesterol from non-aqueous and aqueous solutions. Int J Pharm. 2003;254:155–166.
  • Mel’nikov SM, Seijen ten Hoorn JW, Bertrand B. Can cholesterol absorption be reduced by phytosterols and phytostanols via a cocrystallization mechanism? Chem Phys Lipids. 2004;127:15–33.
  • Compassi S, Werder M, Boffelli D, Weber FE, Hauser H, Schulthess G. Cholesteryl ester absorption by small intestinal brush border membrane is protein-mediated. Biochemistry. 1995;34:16473–16482.
  • Ostlund RE Jr, McGill JB, Zeng CM, et al. Gastrointestinal absorption and plasma kinetics of soy ∆5-phytosterols and phytostanols in humans. Am J Physiol Endocrinol Metab. 2002;282:E911–E916.
  • Lütjohann D, Björkhem I, Beil UF, von Bergmann K. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J Lipid Res. 1995;36:1763–1773.
  • Hui DY, Labonté ED, Howles PN. Development and physiological regulation of intestinal lipid absorption. III. Intestinal transporters and cholesterol absorption. Am J Physiol Gastrointest Liver Physiol. 2008;294:G839–G843.
  • Fitzgerald ML, Mujawar Z, Tamehiro N. ABC transporters, atherosclerosis and inflammation. Atherosclerosis. 2010; Jan 21 [Epub ahead of print].
  • Altmann SW, Davis HR Jr, Zhu LJ, et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004;303: 1201–1204.
  • Brown JM, Rudel LL, Yu L. NPC1L1 (Niemann-Pick C1-like 1) mediates sterol-specific unidirectional transport of non-esterified cholesterol in McArdle-RH7777 hepatoma cells. Biochem J. 2007;406: 273–283.
  • Yamanashi Y, Takada T, Suzuki H. Niemann-Pick C1-like 1 overexpression facilitates ezetimibe-sensitive cholesterol and beta- sitosterol uptake in CaCo-2 cells. J Pharmacol Exp Ther. 2007;320: 559–564.
  • Davis HR Jr, Zhu LJ, Hoos LM, et al. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem. 2004;279:33586–33592.
  • Tang W, Ma Y, Jia L, Ioannou YA, Davies JP, Yu L. Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8. J Lipid Res. 2009;50:293–300.
  • Nguyen D, Dhanasekaran P, Phillips MC, Lund-Katz S. Molecular mechanism of apolipoprotein E binding to lipoprotein particles. Biochemistry. 2009;48:3025–3032.
  • Salen G, Patel S, Batta AK. Sitosterolemia. Cardiovasc Drug Rev. 2002;20:255–270.
  • Wang HH, Patel SB, Carey MC, Wang DQH. Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(-/-) mice. Hematology. 2007;45:998–1006.
  • Wang N, Silver DL, Thiele C, Tall AR. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem. 2001;276:23742–23747.
  • Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci US A. 2004;101:9774–9779.
  • Field FJ, Born E, Mathur SN. LXR/RXR ligand activation enhances basolateral efflux of beta-sitosterol in CaCo-2 cells. J Lipid Res. 2004; 45:905–913.
  • Hovenkamp E, Lourbakos A, Duchateau GSMJE, Tareilus EW, Trautwein EA. Preferential efflux of phytosterols over cholesterol from macrophages. Lipids. 2007;42:1125–1132.
  • Jesch ED, Seo JM, Carr TP, Lee JY. Sitosterol reduces messenger RNA and protein expression levels of Niemann-Pick C1-like 1 in FHs 74 Int cells. Nutr Res. 2009;29:859–866.
  • Cantàfora A, Blotta I, Rivabene R, Pisciotta L, Bertolini S. Evaluation of RNA messengers involved in lipid trafficking of human intestinal cells by reverse-transcription polymerase chain reaction with com- petimer technology and microchip electrophoresis. Electrophoresis. 2003;24:3748–3754.
  • Jain D, Ebine N, Jia X, et al. Corn fiber oil and sitostanol decrease cholesterol absorption independently of intestinal sterol transporters in hamsters. J Nutr Biochem. 2008;19:229–236.
  • Calpe-Berdiel L, Escolà-Gil JC, Ribas V, Navarro-Sastre A, Garcés-Garcés J, Blanco-Vaca F. Changes in intestinal and liver global gene expression in response to a phytosterol-enriched diet. Atherosclerosis. 2005;181:75–85.
  • Brown AW, Hang J, Dussault PH, Carr TP. Plant sterol and stanol substrate specificity of pancreatic cholesterol esterase. J Nutr Biochem. Epub 2009 Jul 15.
  • Julien-David D, Ennahar S, Miesch M, et al. Effects of oxidation on the hydrolysis by cholesterol esterase of sitosteryl esters as compared to a cholesteryl ester. Steroids. 2009;74:832–836.
  • Field FJ, Mathur SN. beta-Sitosterol: esterification by intestinal acylcoenzyme A:cholesterol acyltransferase (ACAT) and its effect on cholesterol esterification. J Lipid Res. 1983;24:409–417.
  • Tavani DM, Nes WR, Billheimer JT. The sterol substrate specificity of acyl CoA:cholesterol acyltransferase from rat liver. J Lipid Res. 1982; 23:774–781.
  • Temel RE, Gebre AK, Parks JS, Rudel LL. Compared with acyl- CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol. J Biol Chem. 2003;278:47594–47601.
  • Ikeda I, Tanaka K, Sugano M, Vahouny GV, Gallo LL. Inhibition of cholesterol absorption in rats by plant sterols. J Lipid Res. 1988;29:1573–1582.
  • Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc. 2003;78:965–978.
  • Law M. Plant sterol and stanol margarines and health. Br Med J. 2000; 320:861–864.
  • Moruisi KG, Oosthuizen W, Opperman AM. Phytosterols/stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis. J Am Coll Nutr. 2006; 25:41–48.
  • Wu T, Fu J, Yang Y, Zhang L, Han J. The effects of phytosterols/stanols on blood lipid profiles: a systematic review with meta-analysis. Asia Pac J Clin Nutr. 2009;18:179–186.
  • Naumann E, Plat J, Kester AD, Mensink RP. The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations. J Am Coll Nutr. 2008;27:117–126.
  • Theuwissen E, Plat J, van der Kallen CJ, van Greevenbroek MM, Mensink RP. Plant stanol supplementation decreases serum triacyl- glycerols in subjects with overt hypertriglyceridemia. Lipids. 2009; 44:1131–1140.
  • Demonty I, Ras RT, van der Knaap HC, et al. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J Nutr. 2009;139:271–284.
  • Doornbos AME, Meynen EM, Duchateau GSMJE, van der Knaap HCM, Trautwein EA. Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hyperc- holesterolaemic subjects. Eur J Clin Nutr. 2006;60:325–333.
  • Matvienko OA, Lewis DS, Swanson M, et al. A single daily dose of soybean phytosterols in ground beef decreases serum total cholesterol and LDL cholesterol in young, mildly hypercholesterolemic men. Am J Clin Nutr. 2002;76:57–64.
  • Plat J, van Onselen EN, van Heugten MM, Mensink RP. Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nutr. 2000;54:671–677.
  • AbuMweis SS, Vanstone CA, Ebine N, et al. Intake of a single morning dose of standard and novel plant sterol preparations for 4 weeks does not dramatically affect plasma lipid concentrations in humans. J Nutr. 2006;136:1012–1016.
  • Lau VWY, Journoud M, Jones PJH. Plant sterols are efficacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons. Am J Clin Nutr. 2005;81: 1351–1358.
  • AbuMweis SS, Vanstone CA, Lichtenstein AH, Jones PJH. Plant sterol consumption frequency affects plasma lipid levels and cholesterol kinetics in humans. Eur J Clin Nutr. 2009;63:747–755.
  • Allen RR, Carson L, Kwik-Uribe C, Evans EM, Erdman JW Jr. Daily consumption of a dark chocolate containing flavanols and added sterol esters affects cardiovascular risk factors in a normotensive population with elevated cholesterol. J Nutr. 2008;138:725–731.
  • Miettinen TA, Vuoristo M, Nissinen M, Jarvinen HJ, Gylling H. Serum, biliary, and fecal cholesterol and plant sterols in colectomized patients before and during consumption of stanol ester margarine. Am J Clin Nutr. 2000;71:1095–1102.
  • Judd JT, Baer DJ, Chen SC, et al. Plant sterol esters lower plasma lipids and most carotenoids in mildly hypercholesterolemic adults. Lipids. 2002;37:33–42.
  • Maki KC, Davidson MH, Umporowicz DM, et al. Lipid responses to plant- sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am J Clin Nutr. 2001;74:33–43.
  • Weststrate JA, Meijer GW. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 1998;52:334–343.
  • Chen SC, Judd JT, Kramer M, Meijer GW, Clevidence BA, Baer DJ. Phytosterol intake and dietary fat reduction are independent and additive in their ability to reduce plasma LDL cholesterol. Lipids. 2009;44:273–281.
  • AbuMweis SS, Barake R, Jones PJ. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food Nutr Res. 2008;52.
  • Clifton PM, Noakes M, Sullivan D, et al. Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal. Eur J Clin Nutr. 2004;58:503–509.
  • Goldberg AC, Ostlund RE Jr, Bateman JH, Schimmoeller L, McPherson TB, Spilburg CA. Effect of plant stanol tablets on low- density lipoprotein cholesterol lowering in patients on statin drugs. Am J Cardiol. 2006;97:376–379.
  • McPherson TB, Ostlund RE, Goldberg AC, Bateman JH, Schimmoeller L, Spilburg CA. Phytostanol tablets reduce human LDL-cholesterol. J Pharm Pharmacol. 2005;57:889–896.
  • Acuff R, Cai D, Dong Z-P, Bell D. The lipid lowering effect of plant sterol ester capsules in hypercholesterolemic subjects. Lipids Health Dis. 2007;6:11.
  • Earnest CP, Mikus CR, Lemieux I, Arsenault BJ, Church TS. Examination of encapsulated phytosterol ester supplementation on lipid indices associated with cardiovascular disease. Nutrition. 2007;23:625–633.
  • Carr TP, Stanek Krogstrand KL, Schlegel VL, Fernandez ML. Stearate-enriched plant sterol esters lower serum LDL cholesterol concentration in normo- and hypercholesterolemic adults. J Nutr. 2009;139:1445–1450.
  • Calpe-Berdiel L, Escolà-Gil JC, Blanco-Vaca F. New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis. 2009;203:18–31.
  • Vanhanen H. Cholesterol malabsorption caused by sitostanol ester feeding and neomycin in pravastatin-treated hypercholesterolaemic patients. Eur J Clin Pharmacol. 1994;47:169–176.
  • Blair SN, Capuzzi DM, Gottlieb SO, Nguyen T, Morgan JM, Cater NB. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol. 2000;86:46–52.
  • De Jong A, Plat J, Bast A, Godschalk RW, Basu S, Mensink RP. Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment. Eur J Clin Nutr. 2008;62:263–273.
  • Goldberg AC, Ostlund RE, Bateman JH, Schimmoeller L, McPherson TB, Spilburg CA. Effect of plant stanol tablets on low- density lipoprotein cholesterol lowering in patients on statin drugs. Am J Cardiol. 2006;97:376–379.
  • Gylling H, Miettinen TA. Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hyper- cholesterolemic non-insulin-dependent diabetic men. J Lipid Res. 1996;37:1776–1785.
  • Gylling H, Radhakrishnan R, Miettinen TA. Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sito- stanol ester margarine: women and dietary sitostanol. Circulation. 1997;96:4226–4231.
  • Neil HAW, Meijer GW, Roe LS. Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread. Atherosclerosis. 2001;156:329–337.
  • O’Neill FH, Brynes A, Mandeno R, et al. Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism. Nutr Metab Cariovasc Dis. 2004;14:133–142.
  • Vuorio AF, Gylling H, Turtola H, Kontula K, Ketonen P, Miettinen TA. Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation. Arterioscler Thromb Vasc Biol. 2000;20:500–506.
  • Gylling H, Miettinen T. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects. Nutr Metab Cardiovasc Dis. 2002;12:19–23.
  • De Jong A, Plat J, Lütjohann D, Mensink RP. Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment. Br J Nutr. 2008;100:937–941.
  • Dujovne CA. New lipid lowering drugs and new effects of old drugs. Curr Opin Lipidol. 1997;8:362–368.
  • Jacobson TA. Improving health outcomes without increasing costs: maximizing the full potential of lipid reduction therapy in the primary and secondary prevention of coronary heart disease. Curr Opin Lipidol. 1997;8:369–374.
  • Chapman MJ. Fibrates in 2003: therapeutic action in atherogenic dys- lipidaemia and future perspectives. Atherosclerosis. 2003;171:1–13.
  • Nigon F, Serfaty-Lacrosnière C, Beucler I, et al. Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fibrate treatment. Clin Chem Lab Med. 2001;39:634–640.
  • Grundy SM, Mok HYI. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia. J Lab Clin Med. 1977;89:354–366.
  • Becker M, Staab D, Von Bergman K. Long-term treatment of severe familial hypercholesterolemia in children: effect of sitosterol and bezafibrate. Pediatrics. 1992;89:138–142.
  • Yeganeh B, Moshtaghi-Kashanian GR, Declercq V, Moghadasian MH. Combination of dietary phytosterols plus niacin or fenofibrate: effects on lipid profile and atherosclerosis in apo E-KO mice. J Nutr Biochem. 2005;16:222–228.
  • Garcia-Calvo M, Lisnock J, Bull HG, et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).ProcNatlAcadSci USA. 2005;102: 8132–8137.
  • Jakulj L, Trip MD, Sudhop T, Von Bergmann K, Kastelein JJ, Vissers MN. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels. J Lipid Res. 2005;46:2692–2698.
  • Birjmohun RS, Hutten BA, Kastelein JJP, Stroes ESG. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2005;45:185–197.
  • Denke MA. Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Am J Clin Nutr. 1995;61:392–396.
  • Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189:19–30.
  • Micallef MA, Garg ML. The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women. J Nutr. 2008;138:1086–1090.
  • Micallef MA, Garg ML. Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyper- lipidemic individuals. Atherosclerosis. 2009;204:476–482.
  • Demonty I, Chan YM, Pelled D, Jones PJH. Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols. Am J Clin Nutr. 2006; 84:1534–1542.
  • Jones PJH, Demonty I, Chan YM, Herzog Y, Pelled D. Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 (PAI-1) concentrations in hypercholesterolemic subjects. Lipids Health Dis. 2007;6:28.
  • Varady KA, Ebine N, Vanstone CA, Parsons WE, Jones PJ. Plant sterols and endurance training combine to favorably alter plasma lipid profiles in previously sedentary hypercholesterolemic adults after 8 wk. Am J Clin Nutr. 2004;80:1159–1166.
  • Alhassan S, Reese KA, Mahurin J, et al. Blood lipid responses to plant stanol ester supplementation and aerobic exercise training. Metabolism. 2006;55:541–549.
  • Fransen HP, de Jong N, Wolfs M, et al. Customary use of plant sterol and plant stanol enriched margarine is associated with changes in serum plant sterol and stanol concentrations in humans. J Nutr. 2007;137:1301–1306.
  • Lütjohann D, von Bergmann K. Phytosterolaemia: diagnosis, characterization and therapeutical approaches. Ann Med. 1997;29:181–184.
  • Salen G, Tint GS, Shefer S. Increased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozygotes with sitosterolemia. Arterioscler Thromb. 1992;12:563–568.
  • Glueck CJ, Speirs J, Tracy T, Streicher P, Illig E, Vandegrift J. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism. 1991;40:842–848.
  • Sudhop T, Gottwald BM, von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism. 2002; 51:1519–1521.
  • Rajaratnam RA, Gylling H, Miettinen TA. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol. 2000;35:1185–1191.
  • Assmann G, Cullen GP, Erbey J, Ramey DR, Kannenberg F, Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) Study. Nutr Metab Cariovasc Dis. 2006;16:13–21.
  • Silbernagel G, Fauler G, Renner W, et al. The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease. J Lipid Res. 2009;50:334–341.
  • Windler E, Zyriax BC, Kuipers F, Linseisen J, Boeing H. Association of plasma phytosterol concentrations with incident coronary heart disease: data from the CORA study, a case-control study of coronary artery disease in women. Atherosclerosis. 2009;203:284–290.
  • Wilund KR, Yu L, Xu F, et al. No association between plasma levels of plant sterols and atherosclerosis in mice and men. Arterioscler Thromb Vasc Biol. 2004;24:2326–2332.
  • Pinedo S, Vissers MN, von Bergmann K, et al. Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC- Norfolk Population Study. J Lipid Res. 2007;48:139–144.
  • Fassbender K, Lütjohann D, Dik MG, et al. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk – the LASA study. Atherosclerosis. 2008;196:283–288.
  • Helske S, Miettinen T, Gylling H, et al. Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves. J Lipid Res. 2008;49:1511–1518.
  • Miettinen TA, Railo M, Lepäntalo M, Gylling H. Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. J Am Coll Cardiol. 2005;45:1794–1801.
  • Mellies MJ, Ishikawa TT, Glueck CJ, Bove K, Morrison J. Phytosterols in aortic tissue in adults and infants. J Lab Clin Med. 1976;88:914–921.
  • Lea LJ, Hepburn PA. Safety evaluation of phytosterol-esters. Part 9: results of a European post-launch monitoring programme. Food Chem Toxicol. 2006;44:1213–1222.
  • Colgan HA, Floyd S, Noone EJ, Gibney MJ, Roche HM. Increased intake of fruit and vegetables and a low-fat diet, with and without low-fat plant sterol-enriched spread consumption: effects on plasma lipoprotein and carotenoid metabolism. J Hum Nutr Diet. 2004; 17:561–569.
  • Noakes M, Clifton P, Ntanios F, Shrapnel W, Record I, McInerney J. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am J Clin Nutr. 2002;75:79–86.
  • Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Jones PJH. No changes in serum fat-soluble vitamin and carotenoid concentrations with the intake of plant sterol/stanol esters in the context of a controlled diet. Metabolism. 2002;51:652–656.
  • Quilez J, Rafecas M, Brufau G, et al. Bakery products enriched with phytosterol esters, a-tocopherol and ß-carotene decrease plasma LDL- cholesterol and maintain plasma ß-carotene concentrations in normo- cholesterolemic men and women. J Nutr. 2003;133:3103–3109.
  • Davidson MH, Maki KC, Umporowicz DM, et al. Safety and toler- ability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women. J Am Coll Nutr. 2001; 20:307–319.
  • Hendriks HFJ, Brink EJ, Meijer GW, Princen HMG, Ntanios FY Safety of long-term consumption of plant sterol esters-enriched spread. Eur J Clin Nutr. 2003;57:681–692.
  • Waalkens-Berendsen DH, Wolterbeek AP, Wijnands MV, Richold M, Hepburn PA. Safety evaluation of phytosterol esters. Part 3. Two- generation reproduction study in rats with phytosterol esters – a novel functional food. Food Chem Toxicol. 1999;37:683–696.
  • Carter BA, Taylor OA, Prendergast DR, et al. Stigmasterol, a soy lipid- derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res. 2007;62:301–306.
  • Baker VA, Hepburn PA, Kennedy SJ, et al. Safety evaluation of phytosterol esters. Part 1. Assessment of oestrogenicity using a combination of in vivo and in vitro assays. Food Chem Toxicol. 1999;37: 13–22.
  • Wolfreys AM, Hepburn PA. Safety evaluation of phytosterol esters. Part 7. Assessment of mutagenic activity of phytosterols, phytosterol esters and the cholesterol derivative, 4-cholesten-3-one. Food Chem Toxicol. 2002;40:461–470.
  • Hovenkamp E, Demonty I, Plat J, Lütjohann D, Mensink RP, Trautwein EA. Biological effects of oxidized phytosterols: a review of the current knowledge. Prog Lipid Res. 2008;47:37–49.
  • Lea LJ, Hepburn PA, Wolfreys AM, Baldrick P. Safety evaluation of phytosterol esters. Part 8. Lack of genotoxicity and subchronic toxicity with phytosterol oxides. Food Chem Toxicol. 2004;42:771–783.
  • Ikeda I, Konno R, Shimizu T, et al. Campest-5-en-3-one, an oxidized derivative of campesterol, activates PPARalpha, promotes energy consumption and reduces visceral fat deposition in rats. Biochim Biophys Acta. 2006;1760:800–807.
  • Konno R, Kaneko Y, Suzuki K, Matsui Y. Effect of 5-Campestenone (24-methylcholest-5-en-3-one) on Zucker diabetic fatty rats as a type 2 diabetes mellitus model. Horm Metab Res. 2005;37:79–83.
  • Suzuki K, Tanaka M, Konno R, Kaneko Y. Effects of 5-campestenone (24-methylcholest-5-en-3-one) on the type 2 diabetes mellitus model animal C57BL/KsJ-db/db mice. Horm Metab Res. 2002; 34:121–126.
  • Kimura Y, Yasukawa K, Takido M, Akihisa T, Tamura T. Inhibitory effect of some oxygenated stigmastane-type sterols on 12-O- tetradecanoylphorbol-13-acetate-induced inflammation in mice. Biol Pharm Bull. 1995;18:1617–1619.
  • Mellies MJ, Burton K, Larsen R, Fixler D, Glueck CJ. Cholesterol, phytosterols, and polyunsaturated/saturated fatty acid ratios during the first 12 months of lactation. Am J Clin Nutr. 1979;32:2383–2389.
  • Mellies MJ, Ishikawa TT, Gartside P, et al. Effects of varying maternal dietary cholesterol and phytosterol in lactating women and their infants. Am J Clin Nutr. 1978;31:1347–1354.
  • Laitinen K, Isolauri E, Kaipiainen L, Gylling H, Miettinen TA. Plant stanol ester spreads as components of a balanced diet for pregnant and breast-feeding women: evaluation of clinical safety. Br J Nutr. 2009;101:1797–1804.
  • Loizou S, Lekakis I, Chrousos GP, Moutsatsou P. beta-Sitosterol exhibits anti-inflammatory activity in human aortic endothelial cells. Mol Nutr Food Res. 2009;54:1–8.
  • Woyengo TA, Ramprasath VR, Jones PJH. Anticancer effects of phytosterols. Eur J Clin Nutr. 2009;63:813–820.
  • Brüll F, Mensink RP, van den Hurk K, Duijvestijn A, Plat J. TLR2 activation is essential to induce a Th1 shift in human peripheral blood mononuclear cells by plant stanols and plant sterols. J Biol Chem. 2010;285:2951–2958.